Position in SYRE
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$187,680
New position
Shares Held
2,114
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#217
of 265 holders
Holding Since
Jun 2026
1 quarter on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fulcrum Asset Management LLP holds $18,796,498 across 30 Biotechnology names. SYRE ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMCR |
Immunocore Holdings plc
|
470,025 | $14,923,293 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
13,252 | $711,234 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
15,333 | $598,140 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
5,049 | $560,590 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,456 | $331,882 | |
| 6 | CELC |
Celcuity Inc.
|
2,808 | $293,772 | |
| 7 | ALMS |
Alumis Inc.
|
7,116 | $200,244 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
This page
|
2,114 | $187,680 |
All Filings in SYRE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $187,680 | 2,114 | Shares | Sole | 2026-08-18 | |
| No filing history on record for this holder in this stock. | ||||||